FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1962588562> ?p ?o ?g. }

• W1962588562 endingPage "4" @default.
• W1962588562 startingPage "iii51" @default.
• W1962588562 abstract "Methotrexate is presently the standard disease modifying antirheumatic drug (DMARD) for patients with active rheumatoid arthritis (RA).1 Despite its short term efficacy in clinical trials and long term effectiveness in clinical practice,2-5 many patients continue to have signs and symptoms of active disease while taking a maximally tolerated dose.Over the past decade there has been increasing interest in the use of combination therapy in patients with RA. Boers and Ramsden published the first systematic review of combination therapy in 1991 and identified two trials that provided moderate or strong evidence; neither of these studies used methotrexate.6 Tugwell and Boers updated this review in 1994 and identified four new trials that provided moderate or strong evidence; two of these trials used methotrexate in a parallel combination strategy.7Verhoeven and colleagues updated this review a second time in 1998 and identified 14 new trials published between August 1992 and July 1997.8 In their analysis, they combined these 14 new trials with the six previous trials and categorised the trials by the strategy of combination therapy: parallel, “step-up”, and “step-down”. Of these 20 trials, six used methotrexate in a parallel combination strategy, one of these trials used methotrexate in a step-down strategy, and two of these trials used methotrexate in a step-up strategy.8 Of the two trials which employed the step-up strategy in patients with an incomplete response to methotrexate, one compared the monoclonal anti-CD4 antibody cM-T412 with placebo and failed to show clinical efficacy,9whereas the other compared cyclosporin with placebo and did demonstrate additional efficacy with the combination compared with placebo.10 With the advent of newer biological treatments directed at cytokines which play a part in the pathophysiology of RA, particularly tumour necrosis factor (TNF),11 additional trials of combination therapy based …" @default.
• W1962588562 created "2016-06-24" @default.
• W1962588562 creator A5026165132 @default.
• W1962588562 creator A5055641523 @default.
• W1962588562 creator A5062192353 @default.
• W1962588562 date "2001-11-01" @default.
• W1962588562 modified "2023-09-27" @default.
• W1962588562 title "Stepping-up from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate." @default.
• W1962588562 cites W105144345 @default.
• W1962588562 cites W134148254 @default.
• W1962588562 cites W1480729244 @default.
• W1962588562 cites W1644571680 @default.
• W1962588562 cites W1970192343 @default.
• W1962588562 cites W1985763670 @default.
• W1962588562 cites W1986215651 @default.
• W1962588562 cites W2010900664 @default.
• W1962588562 cites W2033299724 @default.
• W1962588562 cites W2038693293 @default.
• W1962588562 cites W2054888624 @default.
• W1962588562 cites W2100285949 @default.
• W1962588562 cites W2142500530 @default.
• W1962588562 cites W2145273349 @default.
• W1962588562 cites W2158392523 @default.
• W1962588562 cites W2314052274 @default.
• W1962588562 cites W2319957449 @default.
• W1962588562 cites W2326789779 @default.
• W1962588562 cites W2331320446 @default.
• W1962588562 cites W2401743791 @default.
• W1962588562 doi "https://doi.org/10.1136/ard.60.90003.iii51" @default.
• W1962588562 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1766673" @default.
• W1962588562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11890654" @default.
• W1962588562 hasPublicationYear "2001" @default.
• W1962588562 type Work @default.
• W1962588562 sameAs 1962588562 @default.
• W1962588562 citedByCount "17" @default.
• W1962588562 countsByYear W19625885622014 @default.
• W1962588562 countsByYear W19625885622016 @default.
• W1962588562 crossrefType "journal-article" @default.
• W1962588562 hasAuthorship W1962588562A5026165132 @default.
• W1962588562 hasAuthorship W1962588562A5055641523 @default.
• W1962588562 hasAuthorship W1962588562A5062192353 @default.
• W1962588562 hasConcept C126322002 @default.
• W1962588562 hasConcept C141071460 @default.
• W1962588562 hasConcept C142724271 @default.
• W1962588562 hasConcept C177713679 @default.
• W1962588562 hasConcept C1862650 @default.
• W1962588562 hasConcept C204787440 @default.
• W1962588562 hasConcept C27081682 @default.
• W1962588562 hasConcept C2776999253 @default.
• W1962588562 hasConcept C2777077863 @default.
• W1962588562 hasConcept C2777575956 @default.
• W1962588562 hasConcept C2781059491 @default.
• W1962588562 hasConcept C535046627 @default.
• W1962588562 hasConcept C71924100 @default.
• W1962588562 hasConceptScore W1962588562C126322002 @default.
• W1962588562 hasConceptScore W1962588562C141071460 @default.
• W1962588562 hasConceptScore W1962588562C142724271 @default.
• W1962588562 hasConceptScore W1962588562C177713679 @default.
• W1962588562 hasConceptScore W1962588562C1862650 @default.
• W1962588562 hasConceptScore W1962588562C204787440 @default.
• W1962588562 hasConceptScore W1962588562C27081682 @default.
• W1962588562 hasConceptScore W1962588562C2776999253 @default.
• W1962588562 hasConceptScore W1962588562C2777077863 @default.
• W1962588562 hasConceptScore W1962588562C2777575956 @default.
• W1962588562 hasConceptScore W1962588562C2781059491 @default.
• W1962588562 hasConceptScore W1962588562C535046627 @default.
• W1962588562 hasConceptScore W1962588562C71924100 @default.
• W1962588562 hasLocation W19625885621 @default.
• W1962588562 hasOpenAccess W1962588562 @default.
• W1962588562 hasPrimaryLocation W19625885621 @default.
• W1962588562 hasRelatedWork W185090239 @default.
• W1962588562 hasRelatedWork W1999849541 @default.
• W1962588562 hasRelatedWork W2078631716 @default.
• W1962588562 hasRelatedWork W2097091853 @default.
• W1962588562 hasRelatedWork W2114291971 @default.
• W1962588562 hasRelatedWork W2150976049 @default.
• W1962588562 hasRelatedWork W2183908897 @default.
• W1962588562 hasRelatedWork W2358957077 @default.
• W1962588562 hasRelatedWork W2605002490 @default.
• W1962588562 hasRelatedWork W70445611 @default.
• W1962588562 hasVolume "60 Suppl 3" @default.
• W1962588562 isParatext "false" @default.
• W1962588562 isRetracted "false" @default.
• W1962588562 magId "1962588562" @default.
• W1962588562 workType "article" @default.